TY - JOUR
T1 - Endoscopic and Pathologic Characterization of Papillary Architecture in Struvite Stone Formers
AU - Jaeger, Christopher D.
AU - Rule, Andrew D.
AU - Mehta, Ramila A.
AU - Vaughan, Lisa E.
AU - Vrtiska, Terri J.
AU - Holmes, David R.
AU - McCollough, Cynthia M.
AU - Ziegelmann, Matthew J.
AU - Herrera Hernandez, Loren P.
AU - Lieske, John C.
AU - Krambeck, Amy E.
N1 - Funding Information:
Funding Support: This study was supported by the Mayo Clinic O'Brien Urology Research Center , from the National Institute of Diabetes and Digestive and Kidney Diseases ( U54 DK100227 ), and from the National Center for Advancing Translational Sciences and the Mayo Foundation ( UL1-TR000135 ). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Objective To describe the endoscopic characteristics of renal papillae in struvite stone formers (SFs). Materials and Methods From 2009 to 2014, patients undergoing percutaneous nephrolithotomy were prospectively enrolled in our study. Endoscopic analysis and biopsy of papillae were performed to demonstrate the presence and percentage surface area (SA) of Randall's plaque or ductal plug. Comparison with idiopathic calcium oxalate (CaOx) SF and non-SF controls was performed. Results We identified 29 struvite SFs to compare with 90 idiopathic CaOx SFs and 17 controls. On endoscopic mapping, 28 struvite SFs (97%) demonstrated Randall's plaque and 9 (31%) had plugging. The average mean SA of Randall's plaque in struvite SF (1.5 ± 1.4%) was less than CaOx SFs (3.7 ± 4.3%, P = .0018) and similar to controls (1.7 ± 2.7%, P = .76). Average mean plug SA was similar between struvite SFs, CaOx SFs, and controls. On metabolic assessment, 83% of struvite SFs had at least one urine abnormality, with urinary uric acid and oxalate levels significantly higher among struvite SFs compared to controls (P = .002). Despite lack of active urinary tract infection, interstitial inflammation was more prevalent in struvite SFs compared to CaOx SFs (43.5% vs 7.3%, P = .0001). Conclusions Our findings suggest a limited role for Randall's plaque in struvite stone formation. Struvite SFs have less plaque formation than CaOx SFs, but demonstrate evidence of severe parenchymal inflammation compared to other SFs. The role of this prominent interstitial inflammation requires further study.
AB - Objective To describe the endoscopic characteristics of renal papillae in struvite stone formers (SFs). Materials and Methods From 2009 to 2014, patients undergoing percutaneous nephrolithotomy were prospectively enrolled in our study. Endoscopic analysis and biopsy of papillae were performed to demonstrate the presence and percentage surface area (SA) of Randall's plaque or ductal plug. Comparison with idiopathic calcium oxalate (CaOx) SF and non-SF controls was performed. Results We identified 29 struvite SFs to compare with 90 idiopathic CaOx SFs and 17 controls. On endoscopic mapping, 28 struvite SFs (97%) demonstrated Randall's plaque and 9 (31%) had plugging. The average mean SA of Randall's plaque in struvite SF (1.5 ± 1.4%) was less than CaOx SFs (3.7 ± 4.3%, P = .0018) and similar to controls (1.7 ± 2.7%, P = .76). Average mean plug SA was similar between struvite SFs, CaOx SFs, and controls. On metabolic assessment, 83% of struvite SFs had at least one urine abnormality, with urinary uric acid and oxalate levels significantly higher among struvite SFs compared to controls (P = .002). Despite lack of active urinary tract infection, interstitial inflammation was more prevalent in struvite SFs compared to CaOx SFs (43.5% vs 7.3%, P = .0001). Conclusions Our findings suggest a limited role for Randall's plaque in struvite stone formation. Struvite SFs have less plaque formation than CaOx SFs, but demonstrate evidence of severe parenchymal inflammation compared to other SFs. The role of this prominent interstitial inflammation requires further study.
UR - http://www.scopus.com/inward/record.url?scp=84957085432&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957085432&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2015.12.037
DO - 10.1016/j.urology.2015.12.037
M3 - Article
C2 - 26772639
AN - SCOPUS:84957085432
SN - 0090-4295
VL - 90
SP - 39
EP - 44
JO - Urology
JF - Urology
ER -